Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2008 1
2009 1
2010 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas.
Palanca-Wessels MC, Press OW. Palanca-Wessels MC, et al. Cancer. 2010 Feb 15;116(4 Suppl):1126-33. doi: 10.1002/cncr.24801. Cancer. 2010. PMID: 20127945 Free PMC article. Review.
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.
James SE, Greenberg PD, Jensen MC, Lin Y, Wang J, Till BG, Raubitschek AA, Forman SJ, Press OW. James SE, et al. J Immunol. 2008 May 15;180(10):7028-38. doi: 10.4049/jimmunol.180.10.7028. J Immunol. 2008. PMID: 18453625 Free PMC article.
Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.
Shan D, Ledbetter JA, Press OW. Shan D, et al. Cancer Immunol Immunother. 2000 Mar;48(12):673-83. doi: 10.1007/s002620050016. Cancer Immunol Immunother. 2000. PMID: 10752475
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.
Sharkey RM, Press OW, Goldenberg DM. Sharkey RM, et al. Blood. 2009 Apr 23;113(17):3891-5. doi: 10.1182/blood-2008-11-188896. Epub 2009 Jan 30. Blood. 2009. PMID: 19182204 Free PMC article.